Investment Required To Revitalise Clinical Research Sector

BMI View: Post-apartheid South Africa has underinvested in research and development (R&D), which has had a knock-on effect on the country's ability to compete in the field of clinical research. That said, South Africa still has many advantages. The country is between developed and emerging markets, meaning it has a diverse burden of communicable and non-communicable diseases. Furthermore, clinical research in the country observes internationally harmonised good clinical practice standards and the population has high recruitment rates, treatment-naïve patients and English is a first

To read the full article, please choose one of the following options: